Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume $1.38 -0.01 (-0.72%) Closing price 04:00 PM EasternExtended Trading$1.31 -0.07 (-5.00%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galmed Pharmaceuticals Short Interest DataGalmed Pharmaceuticals (GLMD) has a short interest of 46,300 shares, representing 2.11% of the float (the number of shares available for trading by the public). This marks a -66.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 170,215 shares to cover all short positions.Current Short Interest46,300 sharesPrevious Short Interest136,900 sharesChange Vs. Previous Month-66.18%Dollar Volume Sold Short$75.47 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,650,000 sharesFloat Size2,190,000 sharesShort Percent of Float2.11%Today's Trading Volume1,534,998 sharesAverage Trading Volume170,215 sharesToday's Volume Vs. Average902% Short Selling Galmed Pharmaceuticals? Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLMD Short Interest Over TimeGLMD Days to Cover Over TimeGLMD Percentage of Float Shorted Over Time Galmed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202546,300 shares $75.47 thousand -66.2%2.1%0.1 $1.63 7/15/2025136,900 shares $282.01 thousand +50.0%6.3%0.1 $2.06 6/30/202591,300 shares $167.99 thousand +36.5%4.2%0.1 $1.84 6/15/202566,900 shares $107.04 thousand -65.0%3.1%0 $1.60 5/31/2025191,000 shares $275.04 thousand +1.5%8.6%0.1 $1.44 5/15/2025188,200 shares $237.13 thousand -54.8%8.5%0.1 $1.26 4/30/2025416,100 shares $540.93 thousand +331.6%18.7%0.2 $1.30 4/15/202596,400 shares $135.92 thousand +41.4%4.3%0.1 $1.41 3/31/202568,200 shares $98.21 thousand +40.6%3.1%0.1 $1.44 3/15/202548,500 shares $83.75 thousand +889.8%3.0%0.1 $1.73 Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/20254,900 shares $10.65 thousand +19.5%0.3%0.1 $2.17 2/15/20254,100 shares $10.50 thousand -39.7%0.3%0.1 $2.56 1/31/20256,800 shares $19.07 thousand +13.3%0.4%0.2 $2.81 1/15/20256,000 shares $16.74 thousand -41.2%0.4%0.1 $2.79 12/31/202410,200 shares $32.54 thousand -31.1%0.6%0.1 $3.19 12/15/202414,800 shares $43.96 thousand -35.1%0.9%0.1 $2.97 11/30/202422,800 shares $65.21 thousand +31.0%1.4%0 $2.86 11/15/202417,400 shares $50.98 thousand -62.1%1.1%0 $2.93 10/31/202445,900 shares $153.31 thousand +73.9%3.1%0 $3.34 10/15/202426,400 shares $103.49 thousand -22.8%1.8%0 $3.92 9/30/202434,200 shares $234.61 thousand +9.6%2.3%0 $6.86 9/15/202431,200 shares $128.23 thousand -23.2%5.0%0 $4.11 8/31/202440,600 shares $137.23 thousand +235.5%6.6%0.8 $3.38 8/15/202412,100 shares $3.63 thousand +17.5%0.2%0 $0.30 7/31/202410,300 shares $3.17 thousand +14.4%0.2%0.2 $0.31 7/15/20249,000 shares $2.72 thousand +1,185.7%0.2%0.2 $0.30 6/30/2024700 shares $192.50 -94.9%0.0%0 $0.28 6/15/202413,700 shares $4.56 thousand -42.4%0.2%0.1 $0.33 5/31/202423,800 shares $8.81 thousand -67.3%0.4%0.1 $0.37 5/15/202472,800 shares $27.92 thousand -13.1%1.3%0.4 $0.38 4/30/202483,800 shares $29.50 thousand +6.1%1.5%0.4 $0.35 4/15/202479,000 shares $30.01 thousand +101.5%2.2%0.4 $0.38 3/31/202439,200 shares $13.57 thousand +532.3%1.1%0.2 $0.35 3/15/20246,200 shares $1.89 thousand -84.9%0.2%0 $0.31 2/29/202441,000 shares $16.32 thousand -46.1%1.2%0.4 $0.40 2/15/202476,000 shares $28.89 thousand +560.9%2.1%0.6 $0.38 1/31/202411,500 shares $4.31 thousand -79.1%0.3%0.1 $0.37 1/15/202455,100 shares $25.02 thousand -9.7%1.5%0.3 $0.45 12/31/202361,000 shares $27.76 thousand +65.3%1.7%0.4 $0.46 12/15/202336,900 shares $13.17 thousand -56.9%1.0%0.2 $0.36$100 Trillion “AI Metal” Found in American Ghost Town (Ad)Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.Click here to get the details on this virtual monopoly. 11/30/202385,700 shares $30.42 thousand +564.3%2.4%0.4 $0.36 11/15/202312,900 shares $5.16 thousand +17.3%0.4%0.1 $0.40 10/31/202311,000 shares $4.18 thousand -1.8%0.3%0.2 $0.38 10/15/202311,200 shares $4.59 thousand +75.0%0.3%0.1 $0.41 9/30/20236,400 shares $3.97 thousand +88.2%0.2%0 $0.62 9/15/20233,400 shares $2.52 thousand -52.8%0.1%0 $0.74 8/31/20237,200 shares $5.82 thousand -32.7%0.2%0 $0.81 8/15/202310,700 shares $8.67 thousand -61.1%0.3%0 $0.81 7/31/202327,500 shares $31.63 thousand -92.3%1.5%0.1 $1.15 7/15/2023357,100 shares $517.80 thousand +2,668.2%20.1%1.3 $1.45 6/30/202312,900 shares $37.54 thousand -6.5%0.9%0.1 $2.91 6/15/202313,800 shares $51.47 thousand -14.3%1.0%0.5 $3.73 5/31/202316,100 shares $74.22 thousand -18.7%1.1%0.7 $4.61 5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00 4/30/202317,200 shares $5.33 thousand -6.5%0.1%0.1 $0.31 4/15/202318,400 shares $5.70 thousand -30.3%0.1%0.3 $0.31 3/31/202326,400 shares $11.26 thousand -28.5%0.1%0.3 $0.43 3/15/202336,900 shares $17.24 thousand +58.4%0.2%0.3 $0.47 2/28/202323,300 shares $11.18 thousand -32.1%0.1%0.2 $0.48 2/15/202334,300 shares $20.92 thousand +106.6%0.2%0.2 $0.61 1/31/202316,600 shares $10.97 thousand -88.4%0.1%0.1 $0.66 1/15/2023143,500 shares $115.06 thousand -2.3%0.7%1.1 $0.80 12/30/2022146,900 shares $73.45 thousand +57.3%0.7%1.3 $0.50 12/15/202293,400 shares $27.09 thousand +233.6%0.4%1.1 $0.29 11/30/202228,000 shares $8.17 thousand +53.0%0.1%0.8 $0.29 11/15/202218,300 shares $6.10 thousand -45.9%0.1%0.4 $0.33 10/31/202233,800 shares $12.85 thousand +80.8%0.2%0.6 $0.38 10/15/202218,700 shares $7.26 thousand +22.2%0.1%0.3 $0.39 9/30/202215,300 shares $4.76 thousand -57.5%0.1%0.2 $0.31 9/15/202236,000 shares $16.56 thousand -35.5%0.2%0.4 $0.46 8/31/202255,800 shares $25.90 thousand +234.1%0.3%0.5 $0.46 8/15/202216,700 shares $7.42 thousand -34.0%0.1%0.2 $0.44 7/31/202225,300 shares $12.70 thousand -29.3%0.1%0.2 $0.50 7/15/202235,800 shares $21.65 thousand -66.4%0.2%0.3 $0.60 6/30/2022106,600 shares $69.29 thousand -0.7%0.5%0.9 $0.65 6/15/2022107,300 shares $48.29 thousand +364.5%0.5%1.1 $0.45 5/31/202223,100 shares $11.82 thousand -0.4%0.1%0.2 $0.51 5/15/202223,200 shares $14.11 thousand -27.3%0.1%0.3 $0.61 4/30/202231,900 shares $52.95 thousand -37.6%0.2%0.4 $1.66 4/15/202251,100 shares $83.29 thousand -6.2%0.2%0.9 $1.63 3/31/202254,500 shares $86.66 thousand -47.3%0.3%0.5 $1.59 3/15/2022103,500 shares $127.31 thousand -36.0%0.5%0.8 $1.23 2/28/2022161,700 shares $232.85 thousand -30.9%0.8%1.2 $1.44 2/15/2022234,100 shares $374.56 thousand -17.9%1.1%1.7 $1.60 1/31/2022285,200 shares $462.02 thousand +21.7%1.3%1.8 $1.62 1/15/2022234,300 shares $374.88 thousand +20.5%N/A1.3 $1.60 12/31/2021194,400 shares $353.81 thousand -36.4%1.0%1.1 $1.82 12/15/2021305,500 shares $653.77 thousand +7.0%1.5%2.5 $2.14 11/30/2021285,600 shares $719.71 thousand -15.6%1.4%2.4 $2.52 11/15/2021338,500 shares $1.01 million +24.6%1.7%2.7 $2.98Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad)For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.Click here to get your free advisor matches and start planning your legacy today. 10/29/2021271,700 shares $671.10 thousand -16.9%1.3%2.2 $2.47 10/15/2021326,900 shares $898.98 thousand +2.7%1.6%1.4 $2.75 9/30/2021318,300 shares $888.06 thousand -17.0%1.6%1.4 $2.79 9/15/2021383,700 shares $1.12 million -10.8%1.9%1.6 $2.91 8/31/2021430,100 shares $1.41 million -8.0%2.1%1.7 $3.27 8/13/2021467,500 shares $1.38 million -28.5%2.3%1.4 $2.95 7/30/2021654,000 shares $1.63 million +0.8%3.3%1.8 $2.49 7/15/2021648,700 shares $1.69 million -0.6%3.2%2.4 $2.61 6/30/2021652,500 shares $1.98 million +23.6%3.3%2.3 $3.04 6/15/2021527,900 shares $1.68 million +97.9%2.6%1.8 $3.18 5/28/2021266,800 shares $693.68 thousand -1.4%1.3%0.8 $2.60 5/14/2021270,700 shares $606.37 thousand -16.4%1.4%1 $2.24 4/30/2021323,900 shares $1.09 million -2.4%1.6%0.8 $3.37 4/15/2021331,700 shares $1.09 million +15.1%1.7%0.8 $3.30 3/31/2021288,300 shares $960.04 thousand +30.2%1.5%0.7 $3.33 3/15/2021221,500 shares $775.25 thousand +14.8%1.1%0.5 $3.50 2/26/2021192,900 shares $792.82 thousand +389.6%1.1%0.5 $4.11 2/12/202139,400 shares $212.76 thousand +4.2%0.2%0.1 $5.40 1/29/202137,800 shares $142.70 thousand +49.4%0.2%0.2 $3.78 1/15/202125,300 shares $88.04 thousand -22.6%0.2%0.2 $3.48 12/31/202032,700 shares $106.93 thousand +26.3%0.2%0.3 $3.27 12/15/202025,900 shares $94.79 thousand -29.0%0.2%0.3 $3.66 11/30/202036,500 shares $152.21 thousand +55.3%0.2%0.5 $4.17 11/15/202023,500 shares $79.67 thousand +109.8%0.2%0.3 $3.39 10/30/202011,200 shares $34.38 thousand -49.6%0.1%0.2 $3.07 10/15/202022,200 shares $74.37 thousand -53.0%0.1%0.3 $3.35 9/30/202047,200 shares $166.62 thousand -28.9%0.3%0.5 $3.53 9/15/202066,400 shares $278.88 thousand -65.2%0.4%0.8 $4.20 8/31/2020191,000 shares $932.08 thousand -56.7%1.2%2.3 $4.88 GLMD Short Interest - Frequently Asked Questions What is Galmed Pharmaceuticals' current short interest? Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 46,300 shares of GLMD short. 2.11% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest. What is a good short interest percentage for Galmed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.11% of Galmed Pharmaceuticals' floating shares are currently sold short. Is Galmed Pharmaceuticals' short interest increasing or decreasing? Galmed Pharmaceuticals saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 46,300 shares, a drop of 66.2% from the previous total of 136,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galmed Pharmaceuticals' float size? Galmed Pharmaceuticals currently has issued a total of 1,654,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 2,190,000 shares. How does Galmed Pharmaceuticals' short interest compare to its competitors? 2.11% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galmed Pharmaceuticals: Biofrontera Inc. (2.14%), Portage Biotech Inc. (4.43%), Soligenix Inc. (10.40%), NLS Pharmaceutics Ltd. (5.07%), TransCode Therapeutics Inc. (13.72%), Sonoma Pharmaceuticals, Inc. (1.78%), Talphera, Inc. (0.17%), Adial Pharmaceuticals, Inc. (16.82%), AEON Biopharma, Inc. (3.71%), Addex Therapeutics Ltd. Sponsored ADR (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Galmed Pharmaceuticals stock? Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. GLMD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galmed Pharmaceuticals? A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further. How often is Galmed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Biofrontera Short Interest Data Portage Biotech Short Interest Data Soligenix Short Interest Data NLS Pharmaceutics Short Interest Data TransCode Therapeutics Short Interest Data Sonoma Pharmaceuticals Short Interest Data Talphera Short Interest Data Adial Pharmaceuticals Short Interest Data AEON Biopharma Short Interest Data Addex Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLMD) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access